Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017 confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution (Text with EEA relevance. )

Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017 confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution (Text with EEA relevance. )

Preámbulo 1

recital 1recital 1

recital 2recital 2

recital 3recital 3

recital 4recital 4

recital 5recital 5

recital 6recital 6

recital 7recital 7

recital 8recital 8

recital 9recital 9

recital 10recital 10

recital 11recital 11

recital 12recital 12

recital 13recital 13

recital 14recital 14

Artículo 1Confirmation of the conditions of approval

Artículo 2Amendment to the Annex to Implementing Regulation (EU) 2015/408

Artículo 3Deferred application of Article 2

Artículo 4Entry into force

Citenza

Inteligencia jurídica con fuentes verificables, por Datons.

citenza.io